{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["colorectal cancer", "herbal medicines", "network pharmacology", "patient-derived xenografts", "tumor recurrence", "turmeric"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33552955", "DateRevised": {"Year": "2021", "Month": "02", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "19"}], "Language": ["eng"], "ELocationID": ["574827", "10.3389/fonc.2020.574827"], "Journal": {"ISSN": "2234-943X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol"}, "ArticleTitle": "Turmeric Is Therapeutic <i>in Vivo</i> on\u00a0Patient-Derived Colorectal Cancer Xenografts: Inhibition of Growth, Metastasis, and Tumor Recurrence.", "Pagination": {"StartPage": "574827", "MedlinePgn": "574827"}, "Abstract": {"AbstractText": ["Colorectal cancer is the third most frequently diagnosed cancer worldwide. Clinically, chemotherapeutic agents such as FOLFOX are the mainstay of colorectal cancer treatment. However, the side effects including toxicity of FOLFOX stimulated the enthusiasm for developing adjuvants, which exhibit better safety profile. Turmeric extract (TE), which has been previously shown to suppress the growth of human and murine colon xenografts, was further demonstrated here for its inhibitory effects on colon cancer patient-derived xenografts (PDX). PDX models were successfully established from tissues of colon cancer patients and the PDX preserved the heterogeneous architecture through passages. NOD/SCID mice bearing PDX were treated either with TE or FOLFOX and differential responses toward these treatments were observed. The growth of PDX, metastasis and tumor recurrence in PDX-bearing mice were suppressed after TE treatments with 60% anti-tumor response rate and 83.3% anti-metastasis rate. Mechanistic studies showed that TE reduced tumor cell proliferation, induced cell apoptosis, inhibited metastasis <i>via</i> modulating multiple targets, such as molecules involved in Wnt and Src pathways, EMT and EGFR-related pathways. Nevertheless, FOLFOX treatments inhibited the PDX growth with sharp decreases of mice body weight and only mild anti-metastasis activities were observed. Furthermore, in order to have a better understanding of the underlying mechanisms, network pharmacology was utilized to predict potential targets and mechanism. In conclusion, the present study demonstrated for the first time that oral TE treatment was effective to suppress the growth of colon PDX and the recurrence of colon tumors in mice. The findings obtained from this clinically relevant PDX model would certainly provide valuable information for the potential clinical use of TE in colorectal cancer patients. The application of PDX model was well illustrated here as a good platform to verify the efficacy of multi-targeted herbal extracts."], "CopyrightInformation": "Copyright \u00a9 2021 Li, Yue, Luo, Tsui, Fung, Ng and Lau."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Li", "ForeName": "Mingyue", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Yue", "ForeName": "Grace Gar-Lee", "Initials": "GG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China."}], "LastName": "Luo", "ForeName": "Lianxiang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Tsui", "ForeName": "Stephen Kwok-Wing", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Fung", "ForeName": "Kwok-Pui", "Initials": "KP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Ng", "ForeName": "Simon Siu-Man", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Lau", "ForeName": "Clara Bik-San", "Initials": "CB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867", "ISSNLinking": "2234-943X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cassidy S, Syed BA. Colorectal cancer drugs market. Nat Rev Drug Discov (2017) 16(8):525\u20136. \u00a010.1038/nrd.2017.59", "ArticleIdList": ["10.1038/nrd.2017.59", "28529321"]}, {"Citation": "Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin (2017) 67(3):177\u201393. \u00a010.3322/caac.21395", "ArticleIdList": ["10.3322/caac.21395", "28248415"]}, {"Citation": "Christofori G. New signals from the invasive front. Nature (2006) 441(7092):444\u201350. \u00a010.1038/nature04872", "ArticleIdList": ["10.1038/nature04872", "16724056"]}, {"Citation": "Engstrand J, Nilsson H, Stromberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer (2018) 18(1):78. \u00a010.1186/s12885-017-3925-x", "ArticleIdList": ["10.1186/s12885-017-3925-x", "PMC5769309", "29334918"]}, {"Citation": "Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, et al. Role of targeted therapy in metastatic colorectal cancer. World J Gastrointest Oncol (2016) 8(9):642\u201355. \u00a010.4251/wjgo.v8.i9.642", "ArticleIdList": ["10.4251/wjgo.v8.i9.642", "PMC5027019", "27672422"]}, {"Citation": "Kim BJ, Jeong JH, Kim JH, Kim HS, Jang HJ. The role of targeted agents in the adjuvant treatment of colon cancer: a meta-analysis of randomized phase III studies and review. Oncotarget (2017) 8(19):31112\u20138. \u00a010.18632/oncotarget.16091", "ArticleIdList": ["10.18632/oncotarget.16091", "PMC5458193", "28415706"]}, {"Citation": "Ellis LM, Fidler IJ. Finding the tumor copycat. Therapy fails, patients don\u2019t. Nat Med (2010) 16(9):974\u20135. \u00a010.1038/nm0910-974", "ArticleIdList": ["10.1038/nm0910-974", "20823880"]}, {"Citation": "Mattie M, Christensen A, Chang MS, Yeh W, Said S, Shostak Y, et al. Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics. Neoplasia (2013) 15(10):1138\u201350. \u00a010.1593/neo.13922", "ArticleIdList": ["10.1593/neo.13922", "PMC3819630", "24204193"]}, {"Citation": "Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, et al. A molecularly annotated platform of patient-derived xenografts (\u201cxenopatients\u201d) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov (2011) 1(6):508\u201323. \u00a010.1158/2159-8290.CD-11-0109", "ArticleIdList": ["10.1158/2159-8290.CD-11-0109", "22586653"]}, {"Citation": "Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goere D, Mariani P, et al. \u00a0Characterization of a large panel of patient-derived tumor xenografts\u00a0representing the clinical heterogeneity of human colorectal cancer. Clin Cancer Res (2012) 18(19):5314\u201328. \u00a010.1158/1078-0432.CCR-12-0372", "ArticleIdList": ["10.1158/1078-0432.CCR-12-0372", "22825584"]}, {"Citation": "Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol (2012) 9(6):338\u201350. \u00a010.1038/nrclinonc.2012.61", "ArticleIdList": ["10.1038/nrclinonc.2012.61", "PMC3928688", "22508028"]}, {"Citation": "Seol HS, Kang HJ, Lee SI, Kim NE, Kim TI, Chun SM, et al. Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor. Cancer Lett (2014) 345(1):56\u201364. \u00a010.1016/j.canlet.2013.11.010", "ArticleIdList": ["10.1016/j.canlet.2013.11.010", "PMC7672533", "24333725"]}, {"Citation": "Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov (2014) 4(9):998\u20131013. \u00a010.1158/2159-8290.CD-14-0001", "ArticleIdList": ["10.1158/2159-8290.CD-14-0001", "PMC4167608", "25185190"]}, {"Citation": "Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Arch Physiol Biochem (2008) 114(2):127\u201349. \u00a010.1080/13813450802033958", "ArticleIdList": ["10.1080/13813450802033958", "18484280"]}, {"Citation": "Yue GG, Chan BC, Hon PM, Lee MY, Fung KP, Leung PC, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol (2010) 48(8-9):2011\u201320. \u00a010.1016/j.fct.2010.04.039", "ArticleIdList": ["10.1016/j.fct.2010.04.039", "PMC2910176", "20438793"]}, {"Citation": "Yue GG, Chan BC, Hon PM, Kennelly EJ, Yeung SK, Cassileth BR, et al. Immunostimulatory activities of polysaccharide extract isolated from Curcuma longa. Int J Biol Macromol (2010) 47(3):342\u20137. \u00a010.1016/j.ijbiomac.2010.05.019", "ArticleIdList": ["10.1016/j.ijbiomac.2010.05.019", "PMC2917522", "20609432"]}, {"Citation": "Mohandas KM, Desai DC. Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol (1999) 18(3):118\u201321.", "ArticleIdList": ["10407566"]}, {"Citation": "Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des (2002) 8(19):1695\u2013706. 10.2174/1381612023394016", "ArticleIdList": ["10.2174/1381612023394016", "12171541"]}, {"Citation": "Yue GG-L, Jiang L, Kwok H-F, Lee JK-M, Chan K-M, Fung K-P, et al. Turmeric ethanolic extract possesses stronger inhibitory activities on colon tumour growth than curcumin \u2013 The importance of turmerones. J Funct Foods (2016) 22:565\u201377. \u00a010.1016/j.jff.2016.02.011", "ArticleIdList": ["10.1016/j.jff.2016.02.011"]}, {"Citation": "Puig I, Chicote I, Tenbaum SP, Arques O, Herance JR, Gispert JD, et al. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res (2013) 19(24):6787\u2013801. \u00a010.1158/1078-0432.CCR-12-1740", "ArticleIdList": ["10.1158/1078-0432.CCR-12-1740", "24170545"]}, {"Citation": "Zhang RZ, Zhu X, Bai H, Ning K. Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Front Pharmacol (2019) 10:1\u201314. \u00a010.3389/fphar.2019.00123", "ArticleIdList": ["10.3389/fphar.2019.00123", "PMC6393382", "30846939"]}, {"Citation": "Zhao J, Lv C, Wu QL, Zeng HW, Guo X, Yang J, et al. Computational systems pharmacology reveals an antiplatelet and neuroprotective mechanism of Deng-Zhan-Xi-Xin injection in the treatment of ischemic stroke. Pharmacol Res (2019) 147:1\u201315. \u00a010.1016/j.phrs.2019.104365", "ArticleIdList": ["10.1016/j.phrs.2019.104365", "31348992"]}, {"Citation": "Berger SI, Iyengar R. Network analyses in systems pharmacology. Bioinformatics (2009) 25(19):2466\u201372. \u00a010.1093/bioinformatics/btp465", "ArticleIdList": ["10.1093/bioinformatics/btp465", "PMC2752618", "19648136"]}, {"Citation": "Fan Z, Guo C, Zhang Y, Yao J, Liao L, Dong J. Hongjingtian Injection Inhibits Proliferation and Migration and Promotes Apoptosis in High Glucose-Induced Vascular Smooth Muscle Cells. Drug Des Devel Ther (2019) 13:4115\u201326. \u00a010.2147/DDDT.S220719", "ArticleIdList": ["10.2147/DDDT.S220719", "PMC6901383", "31827318"]}, {"Citation": "Wu W, Zhang Z, Li F, Deng Y, Lei M, Long H, et al. A Network-Based Approach to Explore the Mechanisms of Uncaria Alkaloids in Treating Hypertension and Alleviating Alzheimer\u2019s Disease. Int J Mol Sci (2020) 21(5):1\u201319. \u00a010.3390/ijms21051766", "ArticleIdList": ["10.3390/ijms21051766", "PMC7084279", "32143538"]}, {"Citation": "Zhang Z, Li B, Huang J, Huang S, He D, Peng W, et al. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer. Med Sci Monit (2020) 26:e923327. \u00a010.12659/MSM.923327", "ArticleIdList": ["10.12659/MSM.923327", "PMC7482508", "32866138"]}, {"Citation": "Yue GG-L, Kwok H-F, Lee JK-M, Jiang L, Wong EC-W, Gao S, et al. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice. Pharmacol Res (2016) 111:43\u201357. \u00a010.1016/j.phrs.2016.05.025", "ArticleIdList": ["10.1016/j.phrs.2016.05.025", "27241019"]}, {"Citation": "Li M, Song LH, Yue GG, Lee JK, Zhao LM, Li L, et al. Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species. Sci Rep (2017) 7:42176. \u00a010.1038/srep42176srep42176", "ArticleIdList": ["10.1038/srep42176srep42176", "PMC5299840", "28181527"]}, {"Citation": "Deep G, Jain AK, Ramteke A, Ting H, Vijendra KC, Gangar SC, et al. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin. Mol Cancer (2014) 13:37. \u00a010.1186/1476-4598-13-37", "ArticleIdList": ["10.1186/1476-4598-13-37", "PMC3937432", "24565133"]}, {"Citation": "Yue GG, Lee JK, Kwok HF, Cheng L, Wong EC, Jiang L, et al. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite. Sci Rep (2015) 5:11149. \u00a010.1038/srep11149srep11149", "ArticleIdList": ["10.1038/srep11149srep11149", "PMC4459151", "26053458"]}, {"Citation": "Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I, Fichtner I. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br J Cancer (2002) 87(11):1328\u201335. \u00a010.1038/sj.bjc.6600573", "ArticleIdList": ["10.1038/sj.bjc.6600573", "PMC2408903", "12439725"]}, {"Citation": "Rowan BG, Gimble JM, Sheng M, Anbalagan M, Jones RK, Frazier TP, et al. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS One (2014) 9(2):e89595. \u00a010.1371/journal.pone.0089595", "ArticleIdList": ["10.1371/journal.pone.0089595", "PMC3938488", "24586900"]}, {"Citation": "Buda A, Pignatelli M. E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis. Cell Commun Adhes (2011) 18(6):133\u201343. \u00a010.3109/15419061.2011.636465", "ArticleIdList": ["10.3109/15419061.2011.636465", "22176698"]}, {"Citation": "Liu X, Ji Q, Fan Z, Li Q. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents. Future Oncol (2015) 11(21):2911\u201322. \u00a010.2217/fon.15.235", "ArticleIdList": ["10.2217/fon.15.235", "26414153"]}, {"Citation": "Kirstein MM, Lange A, Prenzler A, Manns MP, Kubicka S, Vogel A. Targeted therapies in metastatic colorectal cancer: a systematic review and assessment of currently available data. Oncologist (2014) 19(11):1156\u201368. \u00a010.1634/theoncologist.2014-0032", "ArticleIdList": ["10.1634/theoncologist.2014-0032", "PMC4221380", "25326159"]}, {"Citation": "Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, et al. Patients\u2019 expectations about effects of chemotherapy for advanced cancer. New Engl J Med (2012) 367(17):1616\u201325. \u00a010.1056/NEJMoa1204410", "ArticleIdList": ["10.1056/NEJMoa1204410", "PMC3613151", "23094723"]}, {"Citation": "Cho SY, Han JY, Na D, Kang W, Lee A, Kim J, et al. A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers. Mol Cancer Ther (2017) 16(10):2178\u201390. \u00a010.1158/1535-7163.MCT-16-0735", "ArticleIdList": ["10.1158/1535-7163.MCT-16-0735", "28611106"]}, {"Citation": "Baba Y, Tamura T, Satoh Y, Gotou M, Sawada H, Ebara S, et al. Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine. Mol Oncol (2017) 11(8):1065\u201377. \u00a010.1002/1878-0261.12074", "ArticleIdList": ["10.1002/1878-0261.12074", "PMC5537908", "28486761"]}, {"Citation": "Devassy JG, Nwachukwu ID, Jones PJ. Curcumin and cancer: barriers to obtaining a health claim. Nutr Rev (2015) 73(3):155\u201365. \u00a010.1093/nutrit/nuu064", "ArticleIdList": ["10.1093/nutrit/nuu064", "26024538"]}, {"Citation": "Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol (2017) 174(11):1325\u201348. \u00a010.1111/bph.13621", "ArticleIdList": ["10.1111/bph.13621", "PMC5429333", "27638428"]}, {"Citation": "Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed (2016) 6(4):383\u201398.", "ArticleIdList": ["PMC4967834", "27516979"]}, {"Citation": "Li M, Yue GG, Tsui SK, Fung KP, Lau CB. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo . Phytomedicine (2018) 46:131\u201341. \u00a010.1016/j.phymed.2018.03.065", "ArticleIdList": ["10.1016/j.phymed.2018.03.065", "30097113"]}, {"Citation": "de Campos PS, Matte BF, Diel LF, Jesus LH, Bernardi L, Alves AM, et al. Low Doses of Curcuma longa Modulates Cell Migration and Cell-Cell Adhesion. Phytother Res (2017) 31(9):1433\u201340. \u00a010.1002/ptr.5872", "ArticleIdList": ["10.1002/ptr.5872", "28782139"]}, {"Citation": "Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol (2012) 3(3):153\u201373. \u00a010.3978/j.issn.2078-6891.2012.030", "ArticleIdList": ["10.3978/j.issn.2078-6891.2012.030", "PMC3418538", "22943008"]}, {"Citation": "Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev (2005) 19(8):877\u201390. \u00a010.1101/gad.1295405", "ArticleIdList": ["10.1101/gad.1295405", "15833914"]}, {"Citation": "Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer (2006) 6(2):107\u201316. \u00a010.1038/nrc1799", "ArticleIdList": ["10.1038/nrc1799", "16491070"]}, {"Citation": "Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis (2007) 28(12):2459\u201366. \u00a010.1093/carcin/bgm178", "ArticleIdList": ["10.1093/carcin/bgm178", "17675336"]}, {"Citation": "Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene (2006) 25(29):4116\u201321. \u00a010.1038/sj.onc.1209439", "ArticleIdList": ["10.1038/sj.onc.1209439", "16491118"]}, {"Citation": "Thorvaldsen TE, Pedersen NM, Wenzel EM, Stenmark H. Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and beta-Catenin Degradation. PloS One (2017) 12(1):e0170508. \u00a010.1371/journal.pone.0170508", "ArticleIdList": ["10.1371/journal.pone.0170508", "PMC5249069", "28107521"]}, {"Citation": "Wu ZQ, Brabletz T, Fearon E, Willis AL, Hu CY, Li XY, et al. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity. Proc Natl Acad Sci U S A (2012) 109(28):11312\u20137. \u00a010.1073/pnas.1203015109", "ArticleIdList": ["10.1073/pnas.1203015109", "PMC3396472", "22745173"]}, {"Citation": "Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet (2007) 39(11):1315\u20137. \u00a010.1038/ng.2007.18", "ArticleIdList": ["10.1038/ng.2007.18", "17934461"]}, {"Citation": "Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 13(1):11\u201326. \u00a010.1038/nrc3419", "ArticleIdList": ["10.1038/nrc3419", "23258168"]}, {"Citation": "Chen A, Xu J, Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene (2006) 25(2):278\u201387. \u00a010.1038/sj.onc.1209019", "ArticleIdList": ["10.1038/sj.onc.1209019", "16170359"]}, {"Citation": "Frame MC. Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta (2002) 1602(2):114\u201330. \u00a010.1016/s0304-419x(02)00040-9", "ArticleIdList": ["10.1016/s0304-419x(02)00040-9", "12020799"]}, {"Citation": "Villegas I, Sanchez-Fidalgo S, Alarcon de la Lastra C. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res (2008) 52(9):1040\u201361. \u00a010.1002/mnfr.200700280", "ArticleIdList": ["10.1002/mnfr.200700280", "18655004"]}, {"Citation": "Teiten MH, Eifes S, Dicato M, Diederich M. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) (2010) 2(1):128\u201362. \u00a010.3390/toxins2010128", "ArticleIdList": ["10.3390/toxins2010128", "PMC3206621", "22069551"]}, {"Citation": "Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Transl Oncol (2009) 2(4):321\u20138. \u00a010.1593/tlo.09193", "ArticleIdList": ["10.1593/tlo.09193", "PMC2781082", "19956394"]}, {"Citation": "Schuell B, Gruenberger T, Kornek GV, Dworan N, Depisch D, Lang F, et al. Side effects during chemotherapy predict tumour response in advanced colorectal cancer. Br J Cancer (2005) 93(7):744\u20138. \u00a010.1038/sj.bjc.6602783", "ArticleIdList": ["10.1038/sj.bjc.6602783", "PMC2361647", "16160693"]}, {"Citation": "Wiela-Hojenska A, Kowalska T, Filipczyk-Cisarz E, Lapinski L, Nartowski K. Evaluation of the toxicity of anticancer chemotherapy in patients with colon cancer. Adv Clin Exp Med (2015) 24(1):103\u201311. \u00a010.17219/acem/38154", "ArticleIdList": ["10.17219/acem/38154", "25923094"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "6", "Day": "21"}, {"Year": "2020", "Month": "11", "Day": "27"}, {"Year": "2021", "Month": "2", "Day": "8", "Hour": "5", "Minute": "43"}, {"Year": "2021", "Month": "2", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33552955", "PMC7856407", "10.3389/fonc.2020.574827"]}}], "PubmedBookArticle": []}